We are building a transformative force
in clinical development.
We are listening to what companies want from their drug development partners. We are listening to understand where the clinical research industry has room to improve. And we are listening to what customers want to achieve for their patients. A breakthrough environment with the agility to promote and respond to changes in clinical development and delivery continues to be an imperative. We are taking action. We are forming Fortrea and along with it a new blueprint for excellence in customer service to equal our renowned scientific expertise.
As a provider of phase I-IV clinical trial management, regulatory guidance, patient access solutions and market access consulting, Fortrea will partner with both emerging and large pharmaceutical, biotechnology, device and diagnostic companies to drive healthcare innovation and improve the lives of patients worldwide.
Harnessing our passion for scientific rigor and decades of clinical trial experience, we’re looking to navigate obstacles with agility and ease. We are problem solvers and creative thinkers committed to opening the doors between promising ideas and proven therapies.
Our countdown begins
As a future spin-off from Labcorp, we will be a new company with decades of history.
We are working now to build our team and prepare for our expected mid-2023 formal separation from Labcorp.
